Does ALEMTUZUMAB Cause Epstein-barr viraemia? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Epstein-barr viraemia have been filed in association with ALEMTUZUMAB (Campath). This represents 0.5% of all adverse event reports for ALEMTUZUMAB.
77
Reports of Epstein-barr viraemia with ALEMTUZUMAB
0.5%
of all ALEMTUZUMAB reports
25
Deaths
6
Hospitalizations
How Dangerous Is Epstein-barr viraemia From ALEMTUZUMAB?
Of the 77 reports, 25 (32.5%) resulted in death, 6 (7.8%) required hospitalization, and 2 (2.6%) were considered life-threatening.
Is Epstein-barr viraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Epstein-barr viraemia?
TACROLIMUS (372)
MYCOPHENOLATE MOFETIL (247)
PREDNISONE (228)
CYCLOSPORINE (219)
CYCLOPHOSPHAMIDE (178)
RITUXIMAB (175)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (144)
FLUDARABINE (134)
METHOTREXATE (127)
PREDNISOLONE (109)
Which ALEMTUZUMAB Alternatives Have Lower Epstein-barr viraemia Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET